Single Incision Versus Three Port Laparoscopic Cholecystectomy

Single Incision Versus Three Port Laparoscopic Cholecystectomy in Symptomatic Gallstones: A Prospective Randomized Study

Laparoscopic cholecystectomy (LC) became the standard treatment for symptomatic gallbladder disease. Single incision laparoscopic surgery (SILS) was developed with the aim of reducing the invasiveness of conventional laparoscopy. The aim of this study was to compare the clinical outcome of single-incision laparoscopic cholecystectomy (SILC) with three port laparoscopic cholecystectomy (TPLC).

Study Overview

• Status: Completed
• Conditions: Laparoscopic Cholecystectomy
• Intervention / Treatment: Device: Single incision laparoscopic cholecystectomy; Device: Three port laparoscopic cholecystectomy

Detailed Description

From February 2014 to September 2016, patients with symptomatic cholecystolithiasis at two university hospitals (Sohag University and Qena University hospitals) were enrolled in this study.

The number of patients needed was calculated. Considering a power of 80% and reliability of 0.05, the investigator found that 76 patients should be present in each group. The study was started with 275 patients for the possible loss of patients and data during the study. Eligible patients (206 patients) were randomly divided equally into two groups (Group 1; SILC, Group 2; TPLC) according to a computer-generated random numbers. Of 103 patients allocated to intervention in each group, 14 patients were excluded from SILC group and 5 patients from TPLC group, and the remaining 89 & 98 patients in SILC & TPLC group respectively were included in the study.

Routine investigations and surgical fitness were done in all cases. Patient demographics, BMI, ASA score, indication for cholecystectomy, operative time, estimated blood loss, success and conversion rate, postoperative pain score, postoperative analgesia requirement, morbidity and mortality, length of hospital stay, and patient cosmetic satisfaction were recorded.

A fixed analgesia protocol with intravenous non-narcotic (ketorolac tromethamine 30 mg) was used twice daily. An opioid (pethidine Hcl 50 mg) was added when the pain cannot be tolerable. Postoperative pain was evaluated according to a visual analogue scale (VAS) from 0 (no pain) to 10 (maximum pain) on the postoperative sixth hour (VAS-6H) and on postoperative day one (VAS-24H). Patient cosmetic satisfaction was recorded at one month follow-up visit on a scale from 1 (worst) to 10 (best). Patients were shown the same photograph of a right sub-costal (Kocher) incision which was rated 0 on the cosmetic scale and were asked to rate their satisfaction based on the previous observation. The study protocol was approved by the local ethical committee. Also, a written informed consent was obtained from all patients' prior recruitment to study.

• Study Type: Interventional
• Enrollment (Actual): 2
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 60 years (ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. preoperative diagnosis of symptomatic gallstones
2. age from 20 to 60 years,
3. American Society of Anesthesiologists (ASA) grade I, II or III,
4. agreement to complete the study requirement.

Exclusion Criteria:

1. patients with contraindication to laparoscopy,
2. suspected Mirizzi syndrome,
3. choledocholithiasis,
4. hepatobiliary malignancy,
5. previous upper abdominal surgery,
6. previous mesh repair of an umbilical hernia,
7. long-term anticoagulant treatment,
8. pregnant female
9. stone more than 2 cm in preoperative ultrasonography.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: DOUBLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: Single incision LC; Single incision laparoscopic cholecystectomy (SILC) performed through a single infra-umbilical incision using a single port device or three ports closely placed.	Device: Single incision laparoscopic cholecystectomy; Laparoscopic cholecystectomy with single port device
SHAM_COMPARATOR: Three port LC; Three port laparoscopic cholecystectomy (TPLC) performed through three different placed trocars	Device: Three port laparoscopic cholecystectomy; Laparoscopic cholecystectomy with three port

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
postoperative pain, visual analogue scale (VAS)	Postoperative pain was evaluated according to a visual analogue scale (VAS) from 0 (no pain) to 10 (maximum pain) on the postoperative hour six (VAS-6H).	at 6 hours
postoperative pain, visual analogue scale (VAS)	Postoperative pain was evaluated according to a visual analogue scale (VAS) from 0 (no pain) to 10 (maximum pain) on the postoperative day one (VAS-24H).	at 24 hours

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
operative duration		From introduction of first trocar to the recovery of patient, up to 10 hours
post operative opioid requirements (questioner)		24 hours
lenght of hospital stay		from recovery of anaesthesia to discharge of patient, up to 4 days
cosmetic satisfactions (aesthetic scale)	Patient aesthetic satisfaction was recorded at one month follow-up visit on a scale from 1 (worst) to 10 (best). Patients were shown the same photograph of a right sub-costal (Kocher) incision which was rated 0 on the aesthetic scale and were asked to rate their satisfaction based on the previous observation.	one month

Collaborators and Investigators

• Sponsor: South Valley University

Study record dates

Study Major Dates

• Study Start: October 1, 2014
• Primary Completion (ACTUAL): October 1, 2016
• Study Completion (ACTUAL): October 1, 2016

Study Registration Dates

• First Submitted: November 25, 2016
• First Submitted That Met QC Criteria: February 23, 2017
• First Posted (ACTUAL): March 1, 2017

Study Record Updates

• Last Update Posted (ACTUAL): March 1, 2017
• Last Update Submitted That Met QC Criteria: February 23, 2017
• Last Verified: February 1, 2017

More Information

Terms related to this study

• Other Study ID Numbers: SVU

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO